Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: contraception Age: Adult Condition: 21-day pack |
Dose: Tablet – 1 tablet Frequency: once daily Duration: 21 days Note: Start dose on 1st day of menstrual cycle. Followed by 7 pill-free days. Start a new pack on the 8th day after the last tablet is taken. Dosing instruction may vary according to the brand. |
|
Indication: contraception Age: Adult Condition: 28-day pack |
Dose: Tablet – 1 tablet Frequency: once daily Note: Start dose on 1st day of menstrual cycle. Taken without interruption at the same time everyday. Dosing instruction may vary according to the brand. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Contraception Age: Postpubertal adolescents |
Dose: Tablet – 1 tablet Frequency: once daily Note: by mouth (oral) |
Administration
- Take at same time daily
- Follow pack instructions
Side Effect
- Arterial/venous thromboembolism
- Edema
- Hypertension
- MI
- Cerebral hemorrhage
- Headache
- Migraine
- Chloasma
- Melasma
- Breast swelling/tenderness
- Menstrual cramps
- Emotional lability
- Abdominal pains
- Appetite changes
- Nausea
- Weight changes
- Application site rxn (if transdermal preparation)
- Gallbladder disease
- Hepatic adenomas
- Optic neuritis
- Vaginal candidiasis
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Paracetamol, Ascorbic acid, Atorvastatin
|
Serum levels may be increased
|
|
Aprepitant, Griseofulvin, Modafinil, Troglitazone, Rifampicin, Topiramate, Nevirapine, Amprenavir, Lopinavir, Nelfinavir, Ritonavir
|
Serum levels may be reduced
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Thrombophlebitis
|
Risk of blood clot formation
|
|
Venous Thromboembolic Disorders
|
Risk of blood clots
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool & dry place, protect from light & moisture. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.